SILO PHARMA, INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $9.1M | $9.8M |
| FY2022 | — | $10.3M | $11.4M |
| FY2023 | — | $6.2M | $3.5M |
| FY2024 | — | $5.0M | $3.9M |
| FY2025 | — | $6.3M | $4.7M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $9.1M | $9.8M |
| FY2022 | — | $10.3M | $11.4M |
| FY2023 | — | $6.2M | $3.5M |
| FY2024 | — | $5.0M | $3.9M |
| FY2025 | — | $6.3M | $4.7M |